DYNAVAX TECHNOLOGIES CORP DYNAV (0IDA.L) Financials
0IDA.L Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | ? | ? |
2023-09-30 | 972.9 million | 368.0 million |
2023-06-30 | 936.4 million | 359.2 million |
2023-03-31 | 969.9 million | 406.2 million |
0IDA.L Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | ? | ? |
2023-09-30 | 30.8 million | 10.7 million |
2023-06-30 | 27.3 million | 10.6 million |
2023-03-31 | 26.3 million | 10.0 million |
0IDA.L Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | 219000 |
2023-09-30 | 14.3 million |
2023-06-30 | 3.4 million |
2023-03-31 | -24.3 million |
0IDA.L Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | - |
2023-09-30 | 720.4 million | - | - |
2023-06-30 | 681.5 million | - | - |
2023-03-31 | 652.0 million | - | - |
0IDA.L Shares Outstanding
0IDA.L Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | - | - | - |
2023-09-30 | 347000 | 14.1 million | - | - |
2023-06-30 | 751000 | 13.0 million | - | - |
2023-03-31 | 1.3 million | 13.6 million | - | - |
0IDA.L Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | - |
2023-09-30 | 69.5 million | 13.2 million |
2023-06-30 | 60.2 million | 13.5 million |
2023-03-31 | 46.9 million | 14.7 million |
0IDA.L
Price: $11.11
52 week price:
Earnings Per Share: 0.75 USD
P/E Ratio: 16.89
Exchange: LSE
Sector: Healthcare
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Market Capitalization: 2.4 million